Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
509
datasets available to search
ShareScore release 0.9.0
Dataset results
509 results for “Hepatitis C Virus”
Study of Ezetimibe for Chronic Hepatitis C Virus (HCV) Infection in Liver Transplant Candidates (EZE-2)
ClinicalTrials.gov study NCT02768545. IPD Sharing: NO. Countries: 1. Publications: 9.
A Study of RO5190591 (Danoprevir) in Combination With Pegasys and Copegus in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1 Virus Infection
ClinicalTrials.gov study NCT00963885. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection
ClinicalTrials.gov study NCT02609659. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Hyperimmune Bovine Colostrum - TRAVELAN™ for Patients With Chronic Hepatitis C Virus Infection Not Responding to Standard Therapy
ClinicalTrials.gov study NCT00956722. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
ClinicalTrials.gov study NCT01804829. IPD Sharing: UNDECIDED. Countries: 1. Publications: 2.
Study of Efficacy and Safety of Grazoprevir (MK-5172)/Elbasvir (MK-8742) Combination Regimen for Treatment-Naïve Participants With Chronic Hepatitis C Virus Genotypes 1, 4, and 6 (MK-5172-060)
ClinicalTrials.gov study NCT02105467. IPD Sharing: YES. Countries: 0. Publications: 4.
Observational Trial of Hepatitis C Virus Infected Patients on Calcineurin Inhibitors
ClinicalTrials.gov study NCT00819026. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Does Hepatitis C Management Protect Egyptian Population Against Severe Corona Virus Disease-2019?
ClinicalTrials.gov study NCT04757272. IPD Sharing: YES. Countries: 1. Publications: 8.
Trial of Peg-interferon Plus Epoetin-alfa for Treatment of Chronic Hepatitis C Virus Infection
ClinicalTrials.gov study NCT00248339. IPD Sharing: Not stated. Countries: 1. Publications: 6.
A Study of Hepatitis C Virus (HCV) Polymerase Inhibitor Pro-Drug in Combination With PEGASYS Plus COPEGUS Compared With PEGASYS Plus COPEGUS in Patients With Chronic Hepatitis C Genotype 1 Infection.
ClinicalTrials.gov study NCT00517439. IPD Sharing: Not stated. Countries: 9. Publications: 1.
A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection
ClinicalTrials.gov study NCT02292719. IPD Sharing: UNDECIDED. Countries: 0. Publications: 2.
A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)
ClinicalTrials.gov study NCT00008463. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection
ClinicalTrials.gov study NCT00164060. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation.
ClinicalTrials.gov study NCT00383864. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Association Between Hepatitis C Virus Infection and Hematologic and Thyroid Cancers
ClinicalTrials.gov study NCT00342641. IPD Sharing: Not stated. Countries: 1. Publications: 3.
The Pathogenesis of Hepatitis C Virus Vertical Transmission
ClinicalTrials.gov study NCT01921400. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Randomized Clinical Trial of Sofosbuvir in Combination With Daclatasvir or Simeprevir for 12 Weeks in Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus Genotype 1 (TNT)
ClinicalTrials.gov study NCT02624063. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 Study
ClinicalTrials.gov study NCT01323244. IPD Sharing: Not stated. Countries: 22. Publications: 1.
Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Virus (HCV) Genotype (GT) 3, GT4, GT5, and GT6 Infection (
ClinicalTrials.gov study NCT02332720. IPD Sharing: YES. Countries: 0. Publications: 2.
Study of a New MVA Vaccine for Hepatitis C Virus
ClinicalTrials.gov study NCT01296451. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.